Edwards' Advanced Hemodynamic Monitoring Platform Receives FDA Clearance
Go back to Edwards' Advanced Hemodynamic Monitoring Platform Receives FDA Clearance| Edwards Lifesciences (NYSE: EW) | Delayed: 86.29 -1.07 (1.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.36 | 52 Week High | $166.87 | |||
| Open | $87.34 | 52 Week Low | $72.20 | |||
| Day High | $87.41 | P/E | 25.08 | |||
| Day Low | $85.75 | EPS | $3.44 | |||
| Volume | 775,781 | |||||
